#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Cholangiocarcinoma+6

Recruiting

InvestigationalNo placebo

A Study Testing BNT329 Safety and Effectiveness in Patients With Advanced Solid Tumors That Express the CA19-9 Tumor Marker

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Cholangiocarcinoma

Recruiting

Registered drugNo placebo

Study of gemcitabine, cisplatin, and pembrolizumab before and after surgery compared to surgery alone for patients with bile duct cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Cholangiocarcinoma+1

Recruiting

Registered drugNo placebo

Testing trifluridine, tipiracil and nanoliposomal irinotecan combination for patients with bile duct or gallbladder cancer after previous treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Irinotecan

Contact Research Centre

Cholangiocarcinoma

Recruiting

Registered drugNo placebo

Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ivosidenib

Contact Research Centre

Cholangiocarcinoma+1

Recruiting

Registered drugNo placebo

Evaluating 68Ga-FAPI-46 PET/CT Scanning for Improved Diagnosis in Patients with Pancreatic Cancer or Bile Duct Cancer Eligible for Curative Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Cholangiocarcinoma+7

Recruiting

Registered drugNo placebo

Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

Registered drugNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Atezolizumab

Contact Research Centre

Cholangiocarcinoma

Recruiting

Registered drugNo placebo

Study of Gemcitabine and Oxaliplatin Infusion for Patients with Non-Metastatic Unresectable Intra-Hepatic Cholangiocarcinoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Oxaliplatin

Contact Research Centre

Cholangiocarcinoma

Recruiting

Registered drugNo placebo

Study on Preventing Liver Recurrence in Patients with Intrahepatic Cholangiocarcinoma Using Floxuridine via Hepatic Arterial Infusion Pump

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Cholangiocarcinoma

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Yttrium-90 Microspheres and Capecitabine for Patients with Operable Intrahepatic Cholangiocarcinoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Cholangiocarcinoma+1

Recruiting

Registered drugNo placebo

Title: Evaluation of Gallium-68 FAPI-46 PET Imaging for Better Detection and Monitoring of Pancreatic Cancer and Bile Duct Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Gallium (68Ga) Chloride

Contact Research Centre

Cholangiocarcinoma

Recruiting

InvestigationalNo placebo

Study of Chemotherapy with or without FUDR/Dexamethasone for Patients with Inoperable Liver Bile Duct Cancer

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Floxuridine

Contact Research Centre

Cholangiocarcinoma+3

Recruiting

Registered drugNo placebo

Study of BOLD-100 with FOLFOX chemotherapy (fluorouracil, folinic acid, and oxaliplatin) in patients with advanced gastrointestinal tumors, colorectal, gastric, or pancreatic cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.